About This Meeting
Due to a scheduling conflict, the Business Development Peer Group, originally scheduled for Wednesday, June 7, will be held on Thursday, June 8.
RSVPs for the original date will be valid for the new date. If you can no longer make it, please let us know!
Join us for a member-only benefit at no charge: DEC Member Peer Groups!
The DEC has partnered with WTW who will expertly facilitate peer group conversations throughout the year.
Network with like-minded members, sharpen professional skills, share best practices, discuss trends and timely field-related topics and build your DEC network through small, facilitated peer groups centered around your profession.
Registration: RSVP Required through eTix
Missed the previous Peer Groups? No worries, you can still attend!
Please Note: Participation in previous Peer Groups does not guarantee a spot, please RSVP through eTix.
8:00 a.m. ET Light Breakfast & Networking
8:30 a.m. Discussion
9:30 a.m. Adjourn
Client Relationship Director
Michael is a client relationship director in Towers Watson’s Chicago office. In this role, he is responsible for the overall relationship between his clients and Willis Towers Watson. He has thirteen years of account management experience.
Michael serves as a liaison to ensure overall client satisfaction and he matches the best consulting resources with client needs. Michael also coordinates overall quality assurance, delivery of the best services and financial management. Michael has experience in helping large organizations think through their human capital strategies as it relates to, compensation and benefits, HR technology and outsourcing, employee engagement, and talent management. He has also helped facilitate global workshops geared toward helping multinationals develop a globally consistent total rewards framework. Before joining the company, he held relationship management positions with leading pharmaceutical and software companies.
Before joining Willis Towers Watson in 2008, he held relationship management positions with leading pharmaceutical and software companies.
Many Thanks To: